Skip to main content

Does Praluent (alirocumab) lower triglycerides?

Medically reviewed by Melisa Puckey, BPharm. Last updated on June 7, 2024.

Official Answer by Drugs.com

Does Praluent lower triglycerides?

No, Praluent (Alirocumab) has little effect on triglyceride levels.

Praluent is taken to reduce Low Density Lipoprotein cholesterol (LDL cholesterol) blood levels.

Click here for a list of medications that treat high triglyceride blood levels.

References

Read next

Praluent vs Repatha: What's the difference?

The differences between Repatha (evolocumab) and Praluent (alirocumab) are their active ingredients, number of treatment indications, dosage forms available and number of strengths available in syringe and pens forms. Continue reading

What are PCSK9 Inhibitors and how do they work?

The PCSK9 inhibitors are used for the treatment of high-risk patients with elevated cholesterol, especially when statins aren't adequate. They work by blocking PCSK9, leaving more receptors available to capture your "bad" cholesterol (LDL) for break down and removal from the blood. Continue reading

How does Praluent work?

Praluent works by inactivating a protein in the liver called proprotein convertase subtilisin kexin 9 (PCSK9). When Praluent inactivates PCSK9, more receptors are available to capture LDL (“bad”) cholesterol for removal from the blood. Lowering LDL in the blood can help to reduce the incidence of heart disease. Continue reading

See also:

Related medical questions

Drug information

Related support groups